Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DMQVRZH)

Drug Name	Vitamin B3 DMQVRZH
Synonyms	Niacin (TN); Niacinamide (TN); Nicotinamide (TN)
Drug Type	Small molecular drug
Structure
Structure	3D MOL			2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

7 Approved Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Hyperlipidemia, familial combined, LPL related	DISL1CE3	N.A.	Approved	[1]
Vitamin deficiency	DISD07I9	5B55-5B71	Approved	[2]
Lipid metabolism disorder	DISEOA7S	5C52.Z	Approved	[3]
Hyperlipidemia	DIS61J3S	5C80.Z	Approved	[4]
Primary hypercholesterolemia	DIS74LB6	5C80.00	Approved	[5]
Psoriasis	DIS59VMN	EA90	Approved	[6]
Chronic renal failure	DISGG7K6	GB61.Z	Approved	[7]
------------------------------------------------------------------------------------


⏷ Show the Full List of 7 Indications(s)

References

1	A standard database for drug repositioning. Sci Data. 2017 Mar 14;4:170029.
2	Hydrosoluble vitamins. Handb Clin Neurol. 2014;120:891-914.
3	Hakozaki T, Minwalla L, Zhuang J, Chhoa M, Matsubara A, Miyamoto K, Greatens A, Hillebrand GG, Bissett DL, Boissy RE: The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol. 2002 Jul;147(1):20-31.
4	Vitamin B3. 2024 Feb 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 JanC.
5	Extended-release niacin (nicotinic acid)/laropiprant. Drugs. 2009 Aug 20;69(12):1665-79.
6	Cosmeceutical Aptitudes of Niacinamide: A Review. Recent Adv Antiinfect Drug Discov. 2021;16(3):196-208.
7	Nicotinamide for photoprotection and skin cancer chemoprevention: A review of efficacy and safety. Exp Dermatol. 2019 Feb;28 Suppl 1:15-22.